Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence
Public ClinicalTrials.gov record NCT05783297. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This research study uses a cluster randomized controlled trial design to evaluate the effectiveness of Treatment Text (TXTXT) intervention on adherence and viral load suppression at 3- and 6- months post intervention initiation for youth and young adults with HIV. A total of 12 clinics will be randomized into one of the following two conditions: 1. Comparison Arm (n=6 clinics)- Clinics randomized to the comparison arm will have participants receive the standard of care for 3 months, followed by a 3-month intervention period. 2. Intervention Arm (n=6 clinics)- Clinics randomized to the intervention arm will have participants receive the TXTXT intervention for 6 months.
Study identification
- NCT ID
- NCT05783297
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 210 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 16 Years to 35 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 17, 2023 (Actual)
- Primary completion
- Aug 1, 2025 (Actual)
- Completion
- Aug 1, 2025 (Actual)
- Last update posted
- Jun 4, 2026
2023 – 2025
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AIDS Healthcare Foundation | Fort Lauderdale | Florida | 33308 | — |
| University of Illinois at Chicago | Chicago | Illinois | 60612 | — |
| Howard Brown Health | Chicago | Illinois | 60613 | — |
| Eskenazi Health | Indianapolis | Indiana | 46202 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| Comprehensive Care Center of Southwest Louisiana | Lake Charles | Louisiana | 70601 | — |
| Corktown Health Center | Detroit | Michigan | 48216 | — |
| KC Care Health Center | Kansas City | Missouri | 64111 | — |
| Duke University | Durham | North Carolina | 27705 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Valley AIDS Council | McAllen | Texas | 78501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05783297, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05783297 live on ClinicalTrials.gov.